Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Rheumatology|October 26, 2006
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytesM Cinelli, S Guiducci, A Del Rosso, et al.
Rheumatology (Oxford, England)|July 7, 2005
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytesA Del Rosso, M Cinelli, S Guiducci, et al.
Annals of the Rheumatic Diseases|August 7, 2004
Infliximab in spondyloarthropathy associated with Crohn's disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestationsS Generini, R Giacomelli, R Fedi, et al.
Annals of the Rheumatic Diseases|February 15, 2005
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvementA Del Rosso, O Distler, A F Milia, et al.
Rheumatology (Oxford, England)|February 1, 2007
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosisF Bartoli, C Angotti, C Fatini, et al.
Seminars in Arthritis and Rheumatism|April 18, 2003
Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosisMarco Matucci Cerinic, G Valentini, G G Sorano, et al.
Rheumatology (Oxford, England)|August 29, 2006
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosisO Kaloudi, G Basta, F Perfetto, et al.
Annals of the Rheumatic Diseases|April 17, 2001
Nerve growth factor and neuropeptides circulating levels in systemic sclerosis (scleroderma)M Matucci-Cerinic, R Giacomelli, A Pignone, et al.
Annals of the Rheumatic Diseases|May 19, 2006
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)W Zhang, M Doherty, E Pascual, et al.
Annals of the Rheumatic Diseases|May 19, 2006
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)W Zhang, M Doherty, T Bardin, et al.
Pageof 6